Yuta Adachi

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

Oxidative Stress

Top Venues

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuta Adachi, Ryo Kimura, Kentaro Hirade, Shogo Yanase, Yuki Nishioka, Natsumi Kasuga, Rui Yamaguchi, Hiromichi Ebi
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS. Nature cancer (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Yuta Adachi, Ryo Kimura, Kentaro Hirade, Hiromichi Ebi
Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers. Cancers 13 (20) (2021)
Yuta Adachi, Naohiro Yanagimura, Chiaki Suzuki, Sakiko Ootani, Azusa Tanimoto, Akihiro Nishiyama, Kaname Yamashita, Koushiro Ohtsubo, Shinji Takeuchi, Seiji Yano
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report. BMC cancer 20 (1) (2020)